A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir®
Zaurbek Ismailov, Pēteris Alberts(Maxygen (United States)), Agnija Rasa, Jurijs Nazarovs(Pauls Stradiņš Clinical University Hospital), Andra Tilgase, Linda Brokāne, Evija Olmane(Pauls Stradiņš Clinical University Hospital), Katrīna Bandere
Cited by 8
Related Papers
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
|Diabetologia|2002|259
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
|Journal of Medicinal Chemistry|2002|211
The advent of oncolytic virotherapy in oncology: The Rigvir® story
|European Journal of Pharmacology|2018|179